| 1. | Cheung N, Mitchell P, Wong T. Diabetic retinopathy[J]. Lancet, 2010, 376(9735): 124-136. DOI: 10.1016/s0140-6736(09)62124-3. | 
				                                                        
				                                                            
				                                                                | 2. | 彭云, 郭千千, 劉軍安, 等. 深圳市社區糖尿病患者視網膜病變防治知識知曉度及影響因素分析[J]. 中華眼底病雜志, 2021, 37(1): 21-26. DOI: 10.3760/cma.j.cn511434-20201119-00570.Peng Y, Guo QQ, Liu JA, et al. A survey of awareness of retinopathy among diabetic patients in communities of Shenzhen[J]. Chin J Ocul Fundus Dis, 2021, 37(1): 21-26. DOI: 10.3760/cma.j.cn511434-20201119-00570. | 
				                                                        
				                                                            
				                                                                | 3. | 蘇加麗, 張怡, 許英. 上海市花木社區居民糖尿病視網膜病變防治知識及行為現況調查研究[J]. 中國全科醫學, 2018, 21(20): 2493-2498. DOI: 10.3969/j.issn.1007-9572.2018.00.136.Su JL, Zhang Y, Xu Y. Survey on the awareness and prevention of diabetic retinopathy among patients with diabetes mellitus and impaired glucose tolerance in the huamu community of Shanghai city[J]. Chinese General Practice, 2018, 21(20): 2493-2498. DOI: 10.3969/j.issn.1007-9572.2018.00.136. | 
				                                                        
				                                                            
				                                                                | 4. | 胡娣, 徐宏輝. 上海某鎮糖尿病患者的糖尿病視網膜病變防治知識知曉情況調查[J]. 上海醫藥, 2019, 40(6): 44-45, 62. DOI: 10.3969/j.issn.1006-1533.2019.06.015.Hu D, Xu HH. Investigation of the knowledge of prevention and treatment of diabetic retinopathy in diabetic patients in a community of Shanghai[J]. Shanghai Medical & Pharmaceutical Journal, 2019, 40(6): 44-45, 62. DOI: 10.3969/j.issn.1006-1533.2019.06.015. | 
				                                                        
				                                                            
				                                                                | 5. | 邵潔, 徐飛燕, 胡燕華. 社區糖尿病患者視網膜病變認知度調查及影響因素分析[J]. 中國社區醫師, 2019, 35(32): 49, 51. DOI: 10.3969/j.issn.1007-614x.2019.32.032.Shao J, Xu FY, Hu YH. Investigation of awareness of retinopathy in community diabetic patients and analysis of its influencing factors[J]. Chinese Community Doctors, 2019, 35(32): 49, 51. DOI: 10.3969/j.issn.1007-614x.2019.32.032. | 
				                                                        
				                                                            
				                                                                | 6. | Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation[J]. Diabet Med, 1998, 15(7): 539-553. DOI: 10.1002/(sici)1096-9136(199807)15:7<539::Aid-dia668>3.0.Co;2-s. | 
				                                                        
				                                                            
				                                                                | 7. | 熊毅, 劉麗萍, 陳雁, 等. 上海淞南社區糖尿病患者對糖尿病視網膜病變的認知度調查[J]. 國際眼科雜志, 2015, 15(7): 1117-1122. DOI: 10.3980/j.issn.1672-5123.2015.7.01.Xiong Y, Liu LP, Chen Y, et al. Survey on the awareness of diabetic retinopathy among people with diabetes in the Songnan community of Shanghai[J]. Int Eye Sci, 2015, 15(7): 1117-1122. DOI: 10.3980/j.issn.1672-5123.2015.7.01. | 
				                                                        
				                                                            
				                                                                | 8. | 中華醫學會糖尿病學分會視網膜病變學組. 糖尿病相關眼病防治多學科中國專家共識(2021年版)[J]. 中華糖尿病雜志, 2021, 13(11): 1026-1042. DOI: 10.3760/cma.j.cn115791-20211006-00534.Diabetic Retinopathy Group of Chinese Diabetes Society. Chinese multidisciplinary expert consensus on the prevention and treatment of diabetic eye disease (2021 edition)[J]. Chin J Diabetes Mellitus, 2021, 13(11): 1026-1042. DOI: 10.3760/cma.j.cn115791-20211006-00534. | 
				                                                        
				                                                            
				                                                                | 9. | 中華醫學會糖尿病學分會視網膜病變學組. 糖尿病視網膜病變防治專家共識[J]. 中華糖尿病雜志, 2018, 10(4): 241-247. DOI: 10.3760/cma.j.issn.1674-5809.2018.04.001.Diabetic Retinopathy Group of Chinese Diabetes Society. Expert consensus on prevention and treatment of diabetic retinopathy[J]. Chin J Diabetes Mellitus, 2018, 10(4): 241-247. DOI: 10.3760/cma.j.issn.1674-5809.2018.04.001. | 
				                                                        
				                                                            
				                                                                | 10. | 李建軍, 徐亮. 白內障影像評估的新方式[J]. 眼科, 2010, 19(2): 76-78.Li JJ, Xu L. A new method of cataract imaging evaluation[J]. Ophthalmol CHN, 2010, 19(2): 76-78. | 
				                                                        
				                                                            
				                                                                | 11. | Zhou Y, Li G, Li H. Automatic cataract classification using deep neural network with discrete state transition[J]. IEEE Trans Med Imaging, 2020, 39(2): 436-446. DOI: 10.1109/tmi.2019.2928229. | 
				                                                        
				                                                            
				                                                                | 12. | 陳淑瑩, 王開杰, 萬修華. 人工智能在白內障診斷和分級中的應用[J]. 國際眼科縱覽, 2021, 45(3): 231-236. DOI: 10.3760/cma.j.issn.1673-5803.2021.03.011.Chen SY, Wang KJ, Wan XH. Artificial intelligence in diagnosis and classification of cataract[J]. Int Rev Ophthalmol, 2021, 45(3): 231-236. DOI: 10.3760/cma.j.issn.1673-5803.2021.03.011. | 
				                                                        
				                                                            
				                                                                | 13. | Hua R, Qu L, Ma B, et al. Diabetic optic neuropathy and its risk factors in Chinese patients with diabetic retinopathy[J]. Invest Ophthalmol Vis Sci, 2019, 60(10): 3514-3519. DOI: 10.1167/iovs.19-26825. | 
				                                                        
				                                                            
				                                                                | 14. | 潘新鋒, 丁園, 陳潤潔, 等. 2018年上海市居民健康素養水平及其影響因素分析[J]. 中國健康教育, 2020, 36(2): 99-102. DOI: 10.16168/j.cnki.issn.1002-9982.2020.02.001.Pan XF, Ding Y, Chen RJ, et al. Analysis on health literacy level and its influencing factors among residents in Shanghai, 2018[J]. Chinese Journal of Health Education, 2020, 36(2): 99-102. DOI: 10.16168/j.cnki.issn.1002-9982.2020.02.001. | 
				                                                        
				                                                            
				                                                                | 15. | 李世聰, 盧玲玲, 嚴維娜, 等. 2021年廣東省成年居民營養健康素養現況特征分析[J]. 中國健康教育, 2022, 38(1): 23-27, 43. DOI: 10.16168/j.cnki.issn.1002-9982.2022.01.005.Li SC, Hu LL, Yan WN, et al. Analysis on the characteristics of nutritional health literacy among adult residents in Guangdong Province, 2021[J]. Chinese Journal of Health Education, 2022, 38(1): 23-27, 43. DOI: 10.16168/j.cnki.issn.1002-9982.2022.01.005. | 
				                                                        
				                                                            
				                                                                | 16. | Kawasaki R, Konta T, Nishida K. Lipid-lowering medication is associated with decreased risk of diabetic retinopathy and the need for treatment in patients with type 2 diabetes: a real-world observational analysis of a health claims database[J]. Diabetes Obes Metab, 2018, 20(10): 2351-2360. DOI: 10.1111/dom.13372. | 
				                                                        
				                                                            
				                                                                | 17. | Gange W, Lopez J, Xu B, et al. Incidence of proliferative diabetic retinopathy and other neovascular sequelae at 5 years following diagnosis of type 2 diabetes[J]. Diabetes care, 2021, 44(11): 2518-2526. DOI: 10.2337/dc21-0228. | 
				                                                        
				                                                            
				                                                                | 18. | Lopez J, Gange WS, Lung K, et al. Response to Comment on Gange et al. Incidence of proliferative diabetic retinopathy and other neovascular sequelae at 5 Years following diagnosis of type 2 diabetes. Diabetes Care 2021; 44: 2518-2526[J]. Diabetes Care, 2022, 45(3): 61-62. DOI: 10.2337/dci21-0057. | 
				                                                        
				                                                            
				                                                                | 19. | Hong T, Mitchell P, de Loryn T, et al. Development and progression of diabetic retinopathy 12 months after phacoemulsification cataract surgery[J]. Ophthalmology, 2009, 116(8): 1510-1514. DOI: 10.1016/j.ophtha.2009.03.003. |